Hexium

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Hexium - overview

Established

2023

Location

Austin, TX, US

Primary Industry

Renewable Energy

About

Hexium is a technology-driven company specializing in isotope enrichment processes, particularly focusing on lithium, to enhance applications in the nuclear sector and related industries. Hexium, founded in 2023 by co-founders Martin Griswold and Jacob Peterson in Austin, US, specializes in isotope enrichment technology. The company has completed 2 deals to date, with its most recent transaction occurring on April 16, 2025. Hexium has raised a total of USD 8.


00 mn in funding through its latest round, an Unspecified Round. Hexium specializes in innovative isotope enrichment technology aimed at advancing the nuclear sector, with a primary focus on lithium. The company's core offering employs Laser Isotope Separation (AVLIS) technology, utilizing precise laser wavelengths to selectively ionize specific isotopes from a vaporized metal stream. This method allows for the efficient separation of enriched isotopes, targeting high-purity outputs while avoiding the complexities associated with traditional mechanical and chemical separation methods.


The enriched isotopes produced are intended for various applications, including clean energy generation, nuclear medicine, and advanced industrial uses, catering to a diverse clientele that spans industries reliant on isotopes. Geographically, Hexium’s products serve markets worldwide, with particular emphasis on regions experiencing bottlenecks in isotope supply, positioning the company as a vital player in both domestic and global nuclear ecosystems. Hexium operates on a transaction structure primarily focused on B2B sales, supplying enriched isotopes to industrial, medical, and energy sector clients. The company engages in direct partnerships with organizations that require high-quality isotopes, facilitating tailored agreements based on specific needs and project requirements.


Transactions typically involve long-term supply contracts that ensure consistent delivery of the enriched isotopes, fundamental for various applications in clean energy and nuclear medicine. Pricing structures for these contracts are established based on the value and purity of the isotopes provided, with flagship products including highly enriched lithium isotopes. Hexium’s strategic approach to optimizing production and maintaining low operational costs reinforces its competitive position within the isotope market, fostering stable revenue streams from its diverse client base. In April 2025, Hexium is set to announce the launch of new products designed to expand its isotope offerings.


The company plans to enter new geographic markets, specifically targeting regions in Europe and Asia by late 2025. The recent funding of USD 8. 00 mn will support these initiatives by enhancing their production capabilities and facilitating entry into these new markets.


Current Investors

R7 Partners, Refactor Capital, MaC Venture Capital

Primary Industry

Renewable Energy

Sub Industries

Renewable Energy

Website

www.hexium.us

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.